These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6953259)

  • 1. Acute lymphoblastic leukemia in a patient receiving penicillamine for Wilson's disease.
    Gilman PA; Holtzman NA
    JAMA; 1982 Jul; 248(4):467-8. PubMed ID: 6953259
    [No Abstract]   [Full Text] [Related]  

  • 2. D-penicillamine-induced IgA deficiency in Wilson's disease.
    Proesmans W; Jaeken J; Eeckels R
    Lancet; 1976 Oct; 2(7989):804-5. PubMed ID: 61477
    [No Abstract]   [Full Text] [Related]  

  • 3. [2 cases of verruciform perforating elastoma after prolonged administration of D-penicillamine in Wilson's disease].
    Sfar Z; Lakhoua H; Hafsia M; Amor RB; Mahfoudh H; Hamza B; Abdallah CB
    Tunis Med; 1977; 55(3):167-8. PubMed ID: 919044
    [No Abstract]   [Full Text] [Related]  

  • 4. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy.
    Dingle J; Havener WH
    Ann Ophthalmol; 1978 Sep; 10(9):1227-30. PubMed ID: 736410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson's disease].
    Farallo M; Amoruso C; Frattini C; Ardissino G; Nebbia G
    Pediatr Med Chir; 2012; 34(5):234-6. PubMed ID: 23342748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephrotic syndrome after treatment with penicillamine in Wilson's disease].
    Hampel R; Meng W; Kallwellis G
    Z Gesamte Inn Med; 1976 Jul; 31(13):507-11. PubMed ID: 960872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
    Ritland S
    Tidsskr Nor Laegeforen; 1987 Aug; 107(22):1770-1. PubMed ID: 3660361
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wilson's disease (hepatocerebral degeneration)].
    Sternlieb I
    Internist (Berl); 1976 Jul; 17(7):342-7. PubMed ID: 780309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Late cutaneous lesions due to penicillamine in a patient with Wilson's disease].
    Christeler A; Delacrétaz J
    Dermatologica; 1969; 139(5):301-6. PubMed ID: 4242275
    [No Abstract]   [Full Text] [Related]  

  • 12. [Penicillamine and other therapeutic methods in the treatment of Wilson's disease].
    Czlonkowska A; Czlonkowski A
    Neurol Neurochir Pol; 1975; 9(3):401-6. PubMed ID: 1097955
    [No Abstract]   [Full Text] [Related]  

  • 13. Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease.
    Svetel M; Sternić N; Pejović S; Kostić VS
    Mov Disord; 2001 May; 16(3):568-9. PubMed ID: 11391761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of prolonged treatment with D-penicillamine on the immune response in Wilson's disease.
    Czlonkowska A
    Eur J Clin Pharmacol; 1977 Dec; 12(4):265-71. PubMed ID: 590312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results].
    Trautmann B; Storch W
    Pharmazie; 1986 Feb; 41(2):126-7. PubMed ID: 3523546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pemphigus in a patient treated with penicillamine for Wilson's disease].
    Degos R; Touraine R; Belaïch S; Revuz J
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):751-3. PubMed ID: 5384189
    [No Abstract]   [Full Text] [Related]  

  • 18. Penicillamine treatment of Wilson's disease and optic neuropathy.
    Lee AH; Lawton NF
    J Neurol Neurosurg Psychiatry; 1991 Aug; 54(8):746. PubMed ID: 1940953
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxic reactions to penicillamine in patients with Wilson's disease.
    Walshe JM
    Postgrad Med J; 1968 Oct; ():Suppl:6-8. PubMed ID: 5706614
    [No Abstract]   [Full Text] [Related]  

  • 20. [Wilson's disease--critical deterioration under high-dose parenteral penicillamine therapy].
    Hilz MJ; Druschky KF; Bauer J; Neundörfer B; Schuierer G
    Dtsch Med Wochenschr; 1990 Jan; 115(3):93-7. PubMed ID: 2298126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.